{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:34:53Z","timestamp":1789500893613,"version":"build-2803163510"},"reference-count":304,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"am","delay-in-days":267,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005197","name":"Hilda and Preston Davis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology &amp; Behavior"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.physbeh.2021.113456","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T12:21:19Z","timestamp":1620735679000},"page":"113456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Gastrointestinal peptides in eating-related disorders"],"prefix":"10.1016","volume":"238","author":[{"given":"Kimberly R.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy H.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.physbeh.2021.113456_bib0001","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/jcem.86.10.7885","article-title":"Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans","volume":"86","author":"Ariyasu","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6762","key":"10.1016\/j.physbeh.2021.113456_bib0002","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.physbeh.2021.113456_bib0003","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/gut.52.7.947","article-title":"Antagonism of ghrelin receptor reduces food intake and body weight gain in mice","volume":"52","author":"Asakawa","year":"2003","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.physbeh.2021.113456_bib0004","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2337\/diabetes.50.8.1714","article-title":"A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans","volume":"50","author":"Cummings","year":"2001","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0005","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/jcem.87.1.8129","article-title":"Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion","volume":"87","author":"Shiiya","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0006","article-title":"Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues","volume":"287","author":"Cummings","year":"2004","journal-title":"Am. J. Physiol."},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0007","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2012-3835","article-title":"Comparison of postprandial profiles of ghrelin, active GLP-1, and total PYY to meals varying in fat and carbohydrate and their association with hunger and the phases of satiety","volume":"98","author":"Gibbons","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0008","doi-asserted-by":"crossref","DOI":"10.1007\/BF03351037","article-title":"Post-prandial decrease of circulating human ghrelin levels","volume":"24","author":"Tschop","year":"2001","journal-title":"J. Endocrinol. Invest."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0009","first-page":"647","article-title":"The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed","volume":"291","author":"Little","year":"2006","journal-title":"Am. J. Physiol."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.kjms.2016.01.006","article-title":"Dose-dependent effect of ghrelin on gastric emptying in rats and the related mechanism of action","volume":"32","author":"Cao","year":"2016","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"11","key":"10.1016\/j.physbeh.2021.113456_bib0011","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1210\/endo.141.11.7873","article-title":"The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion","volume":"141","author":"Wren","year":"2000","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.physbeh.2021.113456_bib0012","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1210\/jcem.86.12.8111","article-title":"Ghrelin enhances appetite and increases food intake in humans","volume":"86","author":"Wren","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.physbeh.2021.113456_bib0013","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1210\/jc.2005-2638","article-title":"Ghrelin stimulates gastric emptying and hunger in normal-weight humans","volume":"91","author":"Levin","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.physbeh.2021.113456_bib0014","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1210\/jc.2005-0409","article-title":"Peptide YY is secreted after oral glucose administration in a gender-specific manner","volume":"90","author":"Kim","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.physbeh.2021.113456_bib0015","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1038\/oby.2007.355","article-title":"Influence of BMI and gender on postprandial hormone responses","volume":"15","author":"Carroll","year":"2007","journal-title":"Obes. (Silver Spring, Md.)"},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0016","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/diabetes.50.4.707","article-title":"Circulating ghrelin levels are decreased in human obesity","volume":"50","author":"Tschop","year":"2001","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0017","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cmet.2017.10.016","article-title":"LEAP2 is an endogenous antagonist of the ghrelin receptor","volume":"27","author":"Ge","year":"2018","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0018","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1172\/JCI111809","article-title":"Cholecystokinin bioactivity in human plasma. molecular forms, responses to feeding, and relationship to gallbladder contraction","volume":"75","author":"Liddle","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.physbeh.2021.113456_bib0019","first-page":"1016","volume":"306","author":"Polak","year":"1975"},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0167-0115(84)90024-7","article-title":"Differential distribution of molecular forms of cholecystokinin in human and porcine small intestinal mucosa","volume":"8","author":"Maton","year":"1984","journal-title":"Regul. Pept."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0021","first-page":"618","article-title":"Disordered food intake and obesity in rats lacking cholecystokinin a receptors","volume":"274","author":"Moran","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"4511","key":"10.1016\/j.physbeh.2021.113456_bib0022","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.7268408","article-title":"Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat","volume":"213","author":"Smith","year":"1981","journal-title":"Science"},{"issue":"5 Pt 2","key":"10.1016\/j.physbeh.2021.113456_bib0023","first-page":"638","article-title":"Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats","volume":"249","author":"Smith","year":"1985","journal-title":"Am. J. Physiol."},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0024","first-page":"776","article-title":"Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats","volume":"246","author":"West","year":"1984","journal-title":"Am. J. Physiol."},{"issue":"6 Pt 2","key":"10.1016\/j.physbeh.2021.113456_bib0025","first-page":"975","article-title":"Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men","volume":"262","author":"Geary","year":"1992","journal-title":"Am. J. Physiol."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0026","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/ajcn\/34.2.154","article-title":"C-terminal octapeptide of cholecystokinin decreases food intake in man","volume":"34","author":"Kissileff","year":"1981","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0027","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0031-9384(82)90230-X","article-title":"C-terminal octapeptide of cholecystokinin decreases food intake in obese men","volume":"29","author":"Pi-Sunyer","year":"1982","journal-title":"Physiol. Behav."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0028","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1037\/h0034870","article-title":"Cholecystokinin decreases food intake in rats","volume":"84","author":"Gibbs","year":"1973","journal-title":"J. Comp. Physiol. Psychol."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0029","first-page":"15","article-title":"Cholecystokinin-decreased food intake in rhesus monkeys","volume":"230","author":"Gibbs","year":"1976","journal-title":"AJP - Legacy"},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0196-9781(82)90041-9","article-title":"Cholecystokinin octapeptide decreases intake of solid food in man","volume":"3","author":"Stacher","year":"1980","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0031","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/cs0890375","article-title":"Cholecystokinin is a satiety hormone in humans at physiological post-prandial plasma concentrations","volume":"89","author":"Ballinger","year":"1979","journal-title":"Clin. Sci."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0032","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/gut.36.2.176","article-title":"Satiety effects of a physiological dose of cholecystokinin in humans","volume":"36","author":"Lieverse","year":"1995","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0033","first-page":"1718","article-title":"Inhibition of food intake in response to intestinal lipid is mediated by cholecystokinin in humans","volume":"277","author":"Matzinger","year":"1999","journal-title":"Am. J. Physiol."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0034","first-page":"562","article-title":"Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in men","volume":"287","author":"Gutzwiller","year":"2004","journal-title":"Am. J. Physiol."},{"issue":"3 Pt 2","key":"10.1016\/j.physbeh.2021.113456_bib0035","first-page":"620","article-title":"Blockade of type A, but not type B, CCK receptors postpones satiety in rhesus monkeys","volume":"265","author":"Moran","year":"1993","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0036","article-title":"Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK","volume":"262","author":"Moran","year":"1992","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0037","first-page":"1149","article-title":"Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans","volume":"280","author":"Beglinger","year":"2001","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0038","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/gut.35.4.501","article-title":"Effect of a low dose of intraduodenal fat on satiety in humans: Studies using the type A cholecystokinin receptor antagonist loxiglumide","volume":"35","author":"Lieverse","year":"1994","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0039","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/0196-9781(91)90197-W","article-title":"Effects of selective cholecystokinin antagonists L364,718 and L365,260 on food intake in rats","volume":"12","author":"Reidelberger","year":"1980","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0040","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1152\/ajpregu.2001.281.1.R254","article-title":"A role for NPY overexpression in the dorsomedial hypothalamus in hyperphagia and obesity of OLETF rats","volume":"281","author":"Bi","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0041","first-page":"1144","article-title":"Decreased responsiveness to dietary fat in otsuka long-evans tokushima fatty rats lacking CCK-A receptors","volume":"277","author":"Schwartz","year":"1999","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0042","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2362.1992.tb01464.x","article-title":"Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man","volume":"22","author":"Eissele","year":"1992","journal-title":"Eur. J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.physbeh.2021.113456_bib0043","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3109\/00365529609009147","article-title":"Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day","volume":"31","author":"\u00d8rskov","year":"1996","journal-title":"Scand. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0044","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2337\/diabetes.48.1.86","article-title":"Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39","volume":"48","author":"Edwards","year":"1999","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.physbeh.2021.113456_bib0045","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1210\/en.2006-0153","article-title":"Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats","volume":"148","author":"Vahl","year":"2007","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0046","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2005.03.011","article-title":"The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway","volume":"1044","author":"Abbott","year":"2005","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.physbeh.2021.113456_bib0047","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2982.2009.01317.x","article-title":"Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat","volume":"21","author":"Bucinskaite","year":"2009","journal-title":"Neurogastroenterol. Motil."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0048","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/en.2008-1221","article-title":"Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms","volume":"150","author":"R\u00fcttimann","year":"2009","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0049","doi-asserted-by":"crossref","DOI":"10.1152\/ajpregu.00356.2011","article-title":"The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1","volume":"301","author":"Hayes","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"12","key":"10.1016\/j.physbeh.2021.113456_bib0050","article-title":"The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty","volume":"304","author":"Plamboeck","year":"2013","journal-title":"Am. J. Physiol."},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0051","article-title":"Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans","volume":"273","author":"Nauck","year":"1997","journal-title":"Am. J. Physiol."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0052","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI990","article-title":"Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans","volume":"101","author":"Flint","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.physbeh.2021.113456_bib0053","first-page":"2131","volume":"132","author":"Baggio","year":"1943"},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0054","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/gut.44.1.81","article-title":"Glucagon-like peptide-1: a potent regulator of food intake in humans","volume":"44","author":"Gutzwiller","year":"1999","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000097585","article-title":"Effects of a preload on reduction of food intake by GLP-1 in healthy subjects","volume":"74","author":"Degen","year":"2006","journal-title":"Digestion"},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0056","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1210\/en.2008-1045","article-title":"Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety","volume":"150","author":"Williams","year":"2009","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0057","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3945\/ajcn.114.083246","article-title":"Effect of glucagon-like peptide-1 receptor antagonism on appetite and food intake in healthy men","volume":"100","author":"Steinert","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.physbeh.2021.113456_bib0058","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.appet.2014.07.009","article-title":"Initial evidence that GLP-1 receptor blockade fails to suppress postprandial satiety or promote food intake in humans","volume":"82","author":"Melhorn","year":"2014","journal-title":"Appetite"},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0059","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00125-005-1705-7","article-title":"Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors","volume":"48","author":"Holst","year":"2005","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.physbeh.2021.113456_bib0060","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1210\/endo.140.11.7143","article-title":"Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine","volume":"140","author":"Hansen","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2021.113456_bib0061","first-page":"458","article-title":"Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig","volume":"271","author":"Deacon","year":"1996","journal-title":"Am. J. Physiol."},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0062","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.2337\/db07-1315","article-title":"Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients","volume":"57","author":"Muscelli","year":"2008","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0063","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000127265","article-title":"Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus","volume":"66","author":"Broberger","year":"1997","journal-title":"Neuroendocrinology"},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0064","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/0016-5085(85)90211-2","article-title":"Human distribution and release of a putative new gut hormone, peptide YY","volume":"89","author":"Adrian","year":"1985","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0065","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1210\/jc.2006-1425","article-title":"Effect of human body weight changes on circulating levels of peptide YY and peptide YY3\u201336","volume":"92","author":"Pfluger","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0066","first-page":"126","article-title":"Reeve J. Primary structures of PYY, [Pro34]PYY, and PYY-(3\u201336) confer different conformations and receptor selectivity","volume":"279","author":"Keire","year":"2000","journal-title":"Am. J. Physiol."},{"issue":"6898","key":"10.1016\/j.physbeh.2021.113456_bib0067","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nature00887","article-title":"Gut hormone PYY3-36 physiologically inhibits food intake","volume":"418","author":"Batterham","year":"2002","journal-title":"Nature (London)"},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0068","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1210\/en.2004-1138","article-title":"Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats","volume":"146","author":"Chelikani","year":"2005","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0069","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1210\/en.2004-1266","article-title":"The role of the vagal nerve in peripheral PYY3\u201336-induced feeding reduction in rats","volume":"146","author":"Koda","year":"2005","journal-title":"Endocrinology"},{"issue":"6898","key":"10.1016\/j.physbeh.2021.113456_bib0070","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nature00887","article-title":"Gut hormone PYY(3-36) physiologically inhibits food intake","volume":"418","author":"Batterham","year":"2002","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.physbeh.2021.113456_bib0071","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJMoa030204","article-title":"Inhibition of food intake in obese subjects by peptide YY3-36","volume":"349","author":"Batterham","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0072","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1152\/ajpregu.00535.2004","article-title":"Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys","volume":"288","author":"Moran","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0073","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/en.2005-0972","article-title":"Attenuated peptide YY release in obese subjects is associated with reduced satiety","volume":"147","author":"le Roux","year":"2006","journal-title":"Endocrinology (Philadelphia)"},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0074","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1053\/j.gastro.2005.09.001","article-title":"Effect of peptide YY3\u201336 on food intake in humans","volume":"129","author":"Degen","year":"1943","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.physbeh.2021.113456_bib0075","first-page":"944","article-title":"Role of peptide YY(3\u201336) in the satiety produced by gastric delivery of macronutrients in rats","volume":"304","author":"Reidelberger","year":"2013","journal-title":"Am. J. Physiol."},{"issue":"1-2","key":"10.1016\/j.physbeh.2021.113456_bib0076","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brainres.2005.02.065","article-title":"Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake","volume":"1043","author":"Abbott","year":"2005","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.physbeh.2021.113456_bib0077","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2826.2005.01330.x","article-title":"Intravenous peptide YY3-36 and Y2 receptor antagonism in the rat: Effects on feeding behaviour","volume":"17","author":"Scott","year":"2005","journal-title":"J. Neuroendocrinol."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0078","first-page":"1062","article-title":"Effects of PYY1\u201336 and PYY3\u201336 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects","volume":"292","author":"Sloth","year":"2007","journal-title":"Am. J. Physiol."},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0079","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/00365519609088805","article-title":"Influence of meal composition on postprandial peripheral plasma concentrations of vasoactive peptides in man","volume":"56","author":"Pedersen-Bjergaard","year":"1996","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"10","key":"10.1016\/j.physbeh.2021.113456_bib0080","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0196-9781(00)00312-0","article-title":"Release of distal gut peptide YY (PYY) by fat in proximal gut depends on CCK","volume":"21","author":"Lin","year":"1980","journal-title":"Peptides"},{"issue":"1 The Psychobio","key":"10.1016\/j.physbeh.2021.113456_bib0081","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1749-6632.1989.tb53264.x","article-title":"Hunger and satiety in anorexia and bulimia nervosa","volume":"575","author":"HALMI","year":"1989","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0082","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/ajcn\/55.6.1093","article-title":"Food intake, hunger, and satiety after preloads in women with eating disorders","volume":"55","author":"Rolls","year":"1992","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0083","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/eat.10016","article-title":"Longitudinal comparison of anorexia nervosa subtypes","volume":"31","author":"Eddy","year":"2002","journal-title":"Int. J. Eat. Disord."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0084","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1176\/appi.ajp.2007.07060951","article-title":"Diagnostic crossover in anorexia nervosa and bulimia nervosa: Implications for DSM-V","volume":"165","author":"Eddy","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0085","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-1450669","article-title":"Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa","volume":"145","author":"Otto","year":"2001","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"10.1016\/j.physbeh.2021.113456_bib0086","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jpsychires.2006.07.021","article-title":"Incomplete restoration of the secretion of ghrelin and PYY compared to insulin after food ingestion following weight gain in anorexia nervosa","volume":"41","author":"Nakahara","year":"2007","journal-title":"J. Psychiatr. Res."},{"issue":"10","key":"10.1016\/j.physbeh.2021.113456_bib0087","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/jcem.86.10.7885","article-title":"Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans","volume":"86","author":"Ariyasu","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0088","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1210\/jc.2002-021669","article-title":"Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa","volume":"88","author":"Nedv\u00eddkov\u00e1","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0089","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1743-7075-9-52","article-title":"Comparison of a high-carbohydrate and high-protein breakfast effect on plasma ghrelin, obestatin, NPY and PYY levels in women with anorexia and bulimia nervosa","volume":"9","author":"Sedlackova","year":"2012","journal-title":"Nutr. Metab."},{"issue":"7","key":"10.1016\/j.physbeh.2021.113456_bib0090","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0306-4530(02)00066-5","article-title":"Fasting plasma ghrelin levels in subtypes of anorexia nervosa","volume":"28","author":"Tanaka","year":"2003","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0091","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-3956(02)00067-5","article-title":"Habitual binge\/purge behavior influences circulating ghrelin levels in eating disorders","volume":"37","author":"Tanaka","year":"2003","journal-title":"J. Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0092","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2265.2003.01886.x","article-title":"Eating pattern and the effect of oral glucose on ghrelin and insulin secretion in patients with anorexia nervosa","volume":"59","author":"Tanaka","year":"2003","journal-title":"Clin. Endocrinol. (Oxford)"},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0093","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.regpep.2004.06.015","article-title":"Effect of nutritional rehabilitation on circulating ghrelin and growth hormone levels in patients with anorexia nervosa","volume":"122","author":"Tanaka","year":"2004","journal-title":"Regulat. Pept."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0094","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ajcn\/85.4.967","article-title":"Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin","volume":"85","author":"Germain","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0095","doi-asserted-by":"crossref","first-page":"165","DOI":"10.33549\/physiolres.931952","article-title":"Changes of plasma obestatin, ghrelin and NPY in anorexia and bulimia nervosa patients before and after a high-carbohydrate breakfast","volume":"60","author":"Sedl\u00e1\u010dkov\u00e1","year":"2011","journal-title":"Physiol. Res."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0096","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000087923","article-title":"Plasma ghrelin in anorexia, bulimia, and binge-eating disorder: Relations with eating patterns and circulating concentrations of cortisol and thyroid hormones","volume":"81","author":"Troisi","year":"2005","journal-title":"Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0097","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1210\/jc.2005-2304","article-title":"Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa","volume":"91","author":"Miljic","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0098","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.biopsych.2007.04.005","article-title":"Obestatin, acyl ghrelin, and des-acyl ghrelin responses to an oral glucose tolerance test in the restricting type of anorexia nervosa","volume":"63","author":"Harada","year":"1969","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0099","article-title":"Plasma levels of active form of ghrelin during oral glucose tolerance test in patients with anorexia nervosa","volume":"149","author":"Nakai","year":"2003","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pscychresns.2014.04.015","article-title":"Abnormal relationships between the neural response to high- and low-calorie foods and endogenous acylated ghrelin in women with active and weight-recovered anorexia nervosa","volume":"223","author":"Holsen","year":"2014","journal-title":"Psychiatry Res. Neuroimag."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0101","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1530\/EJE-10-0523","article-title":"Appetite-regulating hormones cortisol and peptide YY are associated with disordered eating psychopathology, independent of body mass index","volume":"164","author":"Lawson","year":"2011","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"10.1016\/j.physbeh.2021.113456_bib0102","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/eat.22166","article-title":"Adipocytokine levels in women with anorexia nervosa. relationship with weight restoration and disease duration","volume":"46","author":"Terra","year":"2013","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.physbeh.2021.113456_bib0103","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2019.04.021","article-title":"Associations between neuropsychological performance and appetite-regulating hormones in anorexia nervosa and healthy controls: Ghrelin's putative role as a mediator of decision-making","volume":"497","author":"Paslakis","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0104","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12020-015-0684-9","article-title":"Smell\u2013taste dysfunctions in extreme weight\/eating conditions: Analysis of hormonal and psychological interactions","volume":"51","author":"Fern\u00e1ndez-Aranda","year":"2015","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0105","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.psyneuen.2005.01.009","article-title":"Postprandial ghrelin release in anorectic patients before and after weight gain","volume":"30","author":"Otto","year":"2005","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0106","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.psyneuen.2004.01.001","article-title":"Letter to the editor: similar fasting ghrelin levels in binge eating\/purging anorexia nervosa and restrictive anorexia nervosa","volume":"29","author":"Otto","year":"2004","journal-title":"Psychoneuroendocrinology"},{"issue":"8","key":"10.1016\/j.physbeh.2021.113456_bib0107","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1572-0241.2004.30246.x","article-title":"Gastric emptying in patients with restricting and binge purging subtypes of anorexia nervosa","volume":"99","author":"Benini","year":"2004","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0108","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1210\/jc.2009-2196","article-title":"Ghrelin and obestatin circadian levels differentiate bingeing-purging from restrictive anorexia nervosa","volume":"95","author":"Germain","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0109","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1210\/jc.2002-020645","article-title":"Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women","volume":"88","author":"Tolle","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.regpep.2006.11.005","article-title":"Total ghrelin plasma level in patients with the restrictive type of anorexia nervosa","volume":"140","author":"Janas-Kozik","year":"2007","journal-title":"Regul. Pept."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0111","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2005-1878","article-title":"Elevated peptide YY levels in adolescent girls with anorexia nervosa","volume":"91","author":"Misra","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0112","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jpeds.2003.10.036","article-title":"Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation","volume":"144","author":"Soriano-Guillen","year":"2004","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0113","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1210\/jc.2004-1251","article-title":"Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents","volume":"90","author":"Stock","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"25","key":"10.1016\/j.physbeh.2021.113456_bib0114","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/0024-3205(91)90379-P","article-title":"Disturbed cholecystokinin secretion in patients with eating disorders","volume":"48","author":"Philipp","year":"1973","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0115","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0026-0495(93)90216-B","article-title":"Changes in plasma cholecystokinin concentrations after oral glucose tolerance test in anorexia nervosa before and after therapy","volume":"42","author":"Tamai","year":"1993","journal-title":"Metab. Clin. Exp."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0116","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/1098-108X(199401)15:1<63::AID-EAT2260150108>3.0.CO;2-V","article-title":"Satiety and cholecystokinin","volume":"15","author":"Pirke","year":"1994","journal-title":"Int. J. Eat. Disord."},{"issue":"7","key":"10.1016\/j.physbeh.2021.113456_bib0117","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1176\/ajp.149.7.958","article-title":"Regulation of appetite and cholecystokinin secretion in anorexia nervosa","volume":"149","author":"Geracioti","year":"1992","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0118","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0167-0115(91)90202-R","article-title":"Cholecystokinin, vasoactive intestinal peptide and peptide histidine methionine responses to feeding in anorexia nervosa","volume":"36","author":"Harty","year":"1991","journal-title":"Regul. Pept."},{"issue":"10","key":"10.1016\/j.physbeh.2021.113456_bib0119","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0006-3223(97)00044-9","article-title":"Increased cholecystokinin and pancreatic polypeptide responses to a fat-rich meal in patients with restrictive but not bulimic anorexia nervosa","volume":"41","author":"Fujimoto","year":"1969","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0120","doi-asserted-by":"crossref","first-page":"e54457","DOI":"10.1371\/journal.pone.0054457","article-title":"Cholecystokinin revisited: CCK and the hunger trap in anorexia nervosa","volume":"8","author":"Cuntz","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0121","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.psyneuen.2004.10.003","article-title":"Entero-insular axis in children with anorexia nervosa","volume":"30","author":"Tomasik","year":"2005","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0122","first-page":"E565","article-title":"Effects of starvation and short-term refeeding on gastric emptying and postprandial blood glucose regulation in adolescent girls with anorexia nervosa. (Research article: Translational physiology","volume":"315","author":"Heruc","year":"2018","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.physbeh.2021.113456_bib0123","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.peptides.2014.09.006","article-title":"Obese patients have higher circulating protein levels of dipeptidyl peptidase IV","volume":"61","author":"Stengel","year":"1980","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0124","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4088\/JCP.13m08753","article-title":"Appetite regulatory hormones in women with anorexia nervosa: Binge-eating\/purging versus restricting type","volume":"76","author":"Eddy","year":"2015","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0125","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/archpsyc.1990.01810180048008","article-title":"Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa","volume":"47","author":"Kaye","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0126","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.appet.2006.06.008","article-title":"Peptide YY release in anorectic patients after liquid meal","volume":"48","author":"Otto","year":"2007","journal-title":"Appetite"},{"issue":"10","key":"10.1016\/j.physbeh.2021.113456_bib0127","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.peptides.2010.06.022","article-title":"Peripheral leptin and ghrelin receptors are regulated in a tissue-specific manner in activity-based anorexia","volume":"31","author":"Pardo","year":"1980","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2021.113456_bib0128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.npep.2015.04.003","article-title":"The number of preproghrelin mRNA expressing cells is increased in mice with activity-based anorexia","volume":"51","author":"Fran\u00e7ois","year":"2015","journal-title":"Neuropeptides (Edinburgh)."},{"key":"10.1016\/j.physbeh.2021.113456_bib0129","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.psyneuen.2016.02.002","article-title":"Failure to upregulate agrp and orexin in response to activity based anorexia in weight loss vulnerable rats characterized by passive stress coping and prenatal stress experience","volume":"67","author":"Boersma","year":"2016","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0130","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.euroneuro.2010.06.005","article-title":"Acute and chronic suppression of the central ghrelin signaling system reveals a role in food anticipatory activity","volume":"21","author":"Verhagen","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.physbeh.2021.113456_bib0131","first-page":"229","article-title":"Neurobiology driving hyperactivity in activity-based anorexia","volume":"Vol 6","author":"Adan","year":"2010"},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0132","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/erv.2377","article-title":"High levels of physical activity in anorexia nervosa: a systematic review","volume":"23","author":"G\u00fcmmer","year":"2015","journal-title":"Eur. Eat. Disord. Rev."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0133","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/ajcn\/56.4.656","article-title":"Gastric capacity, gastric emptying, and test-meal intake in normal and bulimic women","volume":"56","author":"Geliebter","year":"1992","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0134","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ajcn\/65.1.114","article-title":"Postprandial cholecystokinin release and gastric emptying in patients with bulimia nervosa","volume":"65","author":"Devlin","year":"1997","journal-title":"Am. J. Clin. Nutr."},{"issue":"11","key":"10.1016\/j.physbeh.2021.113456_bib0135","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJM198809153191105","article-title":"Impaired cholecystokinin secretion in bulimia nervosa","volume":"319","author":"Geracioti","year":"1988","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0136","first-page":"819","article-title":"Oral sensory and cephalic hormonal responses to fat and non-fat liquids in bulimia nervosa","volume":"52","author":"Bello","year":"2009","journal-title":"Appetite"},{"issue":"9","key":"10.1016\/j.physbeh.2021.113456_bib0137","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/archpsyc.64.9.1058","article-title":"Clinical features and physiological response to a test meal in purging disorder and bulimia nervosa","volume":"64","author":"Keel","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0138","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0195-6663(92)90200-P","article-title":"Behavioral assessment of satiety in bulimia nervosa","volume":"18","author":"Hadigan","year":"1992","journal-title":"Appetite"},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0139","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ajcn\/87.1.12","article-title":"Meal-induced compositional changes in blood and saliva in persons with bulimia nervosa","volume":"87","author":"Dynesen","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"issue":"8","key":"10.1016\/j.physbeh.2021.113456_bib0140","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1017\/S0033291703008316","article-title":"Ghrelin and leptin responses to food ingestion in bulimia nervosa: Implications for binge-eating and compensatory behaviours","volume":"33","author":"MONTELEONE","year":"2003","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0141","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.psyneuen.2004.07.004","article-title":"Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa","volume":"30","author":"Monteleone","year":"2005","journal-title":"Psychoneuroendocrinology"},{"issue":"8","key":"10.1016\/j.physbeh.2021.113456_bib0142","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.biopsych.2005.01.004","article-title":"Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa","volume":"57","author":"Monteleone","year":"1969","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.physbeh.2021.113456_bib0143","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1210\/jc.2008-1138","article-title":"Plasma obestatin, ghrelin, and ghrelin\/obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosa","volume":"93","author":"Monteleone","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0144","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.psyneuen.2009.07.001","article-title":"Enhanced ghrelin secretion in the cephalic phase of food ingestion in women with bulimia nervosa","volume":"35","author":"Monteleone","year":"2009","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0145","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.regpep.2010.12.012","article-title":"Acipimox during exercise points to an inhibitory feedback of GH on ghrelin secretion in bulimic and healthy women","volume":"167","author":"Nedvidkova","year":"2011","journal-title":"Regul. Pept."},{"key":"10.1016\/j.physbeh.2021.113456_bib0146","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fendo.2019.00108","article-title":"Acipimox administration with exercise induces a co-feedback action of the GH, PP, and PYY on ghrelin associated with a reduction of peripheral lipolysis in bulimic and healthy-weight czech women: a randomized study","volume":"10","author":"Smitka","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0147","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.psyneuen.2004.12.008","article-title":"Hormonal and metabolic responses to acute ghrelin administration in patients with bulimia nervosa","volume":"30","author":"Fassino","year":"2005","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0148","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2265.2004.02176.x","article-title":"Altered ghrelin and peptide YY responses to meals in bulimia nervosa","volume":"62","author":"Kojima","year":"2005","journal-title":"Clin. Endocrinol. (Oxford)"},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0149","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.yhbeh.2006.03.009","article-title":"Ghrelin concentrations and cardiac vagal tone are decreased after pharmacologic and cognitive\u2013behavioral treatment in patients with bulimia nervosa","volume":"50","author":"Tanaka","year":"2006","journal-title":"Horm. Behav."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0150","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.physbeh.2012.02.009","article-title":"Gastric emptying and symptoms of bulimia nervosa: Effect of a prokinetic agent","volume":"106","author":"Devlin","year":"2012","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0151","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/eat.22806","article-title":"Disturbance of gut satiety peptide in purging disorder","volume":"51","author":"Keel","year":"2018","journal-title":"Int. J. Eat. Disord."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0152","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000368160","article-title":"Different effects of cholestyramine on postprandial secretions of cholecystokinin and peptide YY in women with bulimia nervosa","volume":"70","author":"Rigamonti","year":"2015","journal-title":"Neuropsychobiology"},{"issue":"14","key":"10.1016\/j.physbeh.2021.113456_bib0153","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/0006-3223(86)90331-8","article-title":"Naloxone but not CCK-8 may attenuate binge-eating behavior in patients with the bulimia syndrome","volume":"21","author":"Mitchell","year":"1969","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0154","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/eat.22264","article-title":"Preliminary examination of glucagon-like peptide-1 levels in women with purging disorder and bulimia nervosa","volume":"48","author":"Dossat","year":"2015","journal-title":"Int. J. Eat. Disord."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0155","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3945\/ajcn.111.014837","article-title":"Women with bulimia nervosa exhibit attenuated secretion of glucagon-like peptide 1, pancreatic polypeptide, and insulin in response to a meal","volume":"94","author":"Naess\u00e9n","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0156","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.psychres.2008.06.040","article-title":"Glucagon-like peptide-1 secretion in bulimia nervosa","volume":"169","author":"Brambilla","year":"2009","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0157","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1210\/endo-124-3-1438","article-title":"Evidence for regulation of peptide-YY release by the proximal gut","volume":"124","author":"Greeley","year":"1989","journal-title":"Endocrinology (Philadelphia)"},{"issue":"10","key":"10.1016\/j.physbeh.2021.113456_bib0158","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0196-9781(00)00312-0","article-title":"Release of distal gut peptide YY (PYY) by fat in proximal gut depends on CCK","volume":"21","author":"Lin","year":"1980","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0159","first-page":"145","article-title":"Postprandial peptide YY release is mediated by cholecystokinin","volume":"175","author":"McFadden","year":"1992","journal-title":"Surg. Gynecol. Obstet."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0160","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1053\/j.gastro.2003.11.007","article-title":"Independent influences of body mass and gastric volumes on satiation in humans","volume":"126","author":"Delgado-aros","year":"1943","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0161","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2337\/diabetes.54.5.1371","article-title":"Differential association of basal and postprandial plasma ghrelin with leptin, insulin, and type 2 diabetes","volume":"54","author":"Erdmann","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2021.113456_bib0162","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.physbeh.2014.02.043","article-title":"Gastric and intestinal satiation in obese and normal weight healthy people","volume":"129","author":"Meyer-Gerspach","year":"2014","journal-title":"Physiol. Behav."},{"issue":"10","key":"10.1016\/j.physbeh.2021.113456_bib0163","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJMoa030204","article-title":"Inhibition of food intake in obese subjects by peptide YY3-36","volume":"349","author":"Batterham","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0164","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1210\/jcem.87.6.8738","article-title":"Food fails to suppress ghrelin levels in obese humans","volume":"87","author":"English","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0165","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1743-7075-6-32","article-title":"Pre- and post- prandial appetite hormone levels in normal weight and severely obese women","volume":"6","author":"Carlson","year":"2009","journal-title":"Nutr. Metab."},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0166","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2006.10.025","article-title":"Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people","volume":"131","author":"Vazquez Roque","year":"1943","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0167","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1210\/jc.2004-1216","article-title":"Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects","volume":"90","author":"le Roux","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.physbeh.2021.113456_bib0168","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1172\/JCI125332","article-title":"LEAP2 changes with body mass and food intake in humans and mice","volume":"129","author":"Mani","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0169","first-page":"129","article-title":"Effects of fat, protein, and carbohydrate and protein load on appetite, plasma cholecystokinin, peptide YY, and ghrelin, and energy intake in lean and obese men","volume":"303","author":"Brennan","year":"2012","journal-title":"Am. J. Physiol."},{"issue":"21","key":"10.1016\/j.physbeh.2021.113456_bib0170","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJMoa012908","article-title":"Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery","volume":"346","author":"Cummings","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.physbeh.2021.113456_bib0171","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ijo.0803001","article-title":"Ghrelin increases food intake in obese as well as lean subjects","volume":"29","author":"Druce","year":"2005","journal-title":"Int. J. Obes."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0172","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1463-1326.2000.00070.x","article-title":"Disturbed release of gastrointestinal peptides in anorexia nervosa and in obesity","volume":"2","author":"Baranowska","year":"2000","journal-title":"Diabetes Obes. Metab."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0173","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3945\/ajcn.110.007583","article-title":"Marked differences in gustatory and gastrointestinal sensitivity to oleic acid between lean and obese men","volume":"93","author":"Stewart","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"issue":"8","key":"10.1016\/j.physbeh.2021.113456_bib0174","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3109\/00365528608996403","article-title":"VIP and prolactin release in response to meals","volume":"21","author":"Hill","year":"1986","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.physbeh.2021.113456_bib0175","article-title":"Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome","author":"Zwirska-Korczala","year":"2007","journal-title":"J. Physiol. Pharmacol."},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0176","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/0016-5085(94)90397-2","article-title":"Satiety effects of cholecystokinin in humans","volume":"106","author":"Lieverse","year":"1994","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0177","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1023\/A:1018806129102","article-title":"Distal small bowel hormones: correlation with fasting antroduodenal motility and gastric emptying","volume":"43","author":"N\u00e4slund","year":"1998","journal-title":"Dig. Dis. Sci."},{"issue":"8","key":"10.1016\/j.physbeh.2021.113456_bib0178","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/sj.ijo.0801655","article-title":"The role of postprandial releases of insulin and incretin hormones in meal-induced satiety\u2014effect of obesity and weight reduction","volume":"25","author":"Verdich","year":"2001","journal-title":"Int. J. Obes."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0179","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1210\/jc.2009-2054","article-title":"Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men","volume":"95","author":"Carr","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.physbeh.2021.113456_bib0180","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/ijo.2008.157","article-title":"Postprandial changes in gut regulatory peptides in gastric bypass patients","volume":"32","author":"Holdstock","year":"2008","journal-title":"Int. J. Obes."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0181","first-page":"294","article-title":"Gastric emptying, mouth-to-cecum transit, and glycemic, insulin, incretin, and energy intake responses to a mixed-nutrient liquid in lean, overweight, and obese males","volume":"304","author":"Seimon","year":"2013","journal-title":"Am. J. Physiol."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0182","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2004-814222","article-title":"Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion","volume":"36","author":"Lugari","year":"2004","journal-title":"Horm. Metab. Res."},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0183","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/gut.38.6.916","article-title":"Attenuated GLP-1 secretion in obesity: cause or consequence?","volume":"38","author":"Ranganath","year":"1996","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0184","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.sla.0000183349.16877.84","article-title":"Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters","volume":"243","author":"le Roux","year":"2006","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0185","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1210\/jc.2005-0904","article-title":"Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects","volume":"91","author":"Mor\u00ednigo","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0186","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s11695-012-0622-3","article-title":"Metabolic and hormonal changes after laparoscopic roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial","volume":"22","author":"Peterli","year":"2012","journal-title":"Obes. Surg."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0187","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.ijo.0800818","article-title":"Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men","volume":"23","author":"Naslund","year":"1999","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0188","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1079\/BJN20031064","article-title":"Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects","volume":"91","author":"N\u00e4slund","year":"2004","journal-title":"Br. J. Nutr."},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0189","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.ijo.0801627","article-title":"The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity","volume":"25","author":"Flint","year":"2001","journal-title":"Int. J. Obes."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0190","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00125-018-4810-0","article-title":"Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight\/obese individuals: A randomised, crossover study","volume":"62","author":"Bergmann","year":"2019","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.physbeh.2021.113456_bib0191","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/ijo.2016.121","article-title":"Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after roux-en-Y gastric bypass surgery","volume":"40","author":"Svane","year":"2005","journal-title":"Int. J. Obes."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0192","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cmet.2006.08.001","article-title":"Critical role for peptide YY in protein-mediated satiation and body-weight regulation","volume":"4","author":"Batterham","year":"2006","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0193","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1210\/jc.2004-1076","article-title":"Effects of roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin","volume":"90","author":"Korner","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0194","article-title":"Abnormalities of leptin and ghrelin regulation in obesity-prone juvenile rats","volume":"285","author":"Levin","year":"2003","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0195","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1440-1746.2010.06563.x","article-title":"Impaired postprandial releases\/syntheses of ghrelin and PYY3-36 and blunted responses to exogenous ghrelin and PYY3-36 in a rodent model of diet-induced obesity","volume":"26","author":"Xu","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0196","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.yhbeh.2013.09.004","article-title":"Reduced CCK signaling in obese-prone rats fed a high fat diet","volume":"64","author":"Duca","year":"2013","journal-title":"Horm. Behav."},{"issue":"8","key":"10.1016\/j.physbeh.2021.113456_bib0197","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/jn\/135.8.1953","article-title":"Adaptation to a high-fat diet leads to hyperphagia and diminished sensitivity to cholecystokinin in rats","volume":"135","author":"Savastano","year":"2005","journal-title":"J. Nutr."},{"issue":"8","key":"10.1016\/j.physbeh.2021.113456_bib0198","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0196-9781(98)00096-5","article-title":"Rats maintained on high-fat diets exhibit reduced satiety in response to CCK and bombesin","volume":"19","author":"Covasa","year":"1980","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2021.113456_bib0199","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.physbeh.2017.06.011","article-title":"Exogenous glucagon-like peptide-1 reduces body weight and cholecystokinin-8 enhances this reduction in diet-induced obese male rats","volume":"179","author":"Mhalhal","year":"2017","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2021.113456_bib0200","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.appet.2016.12.001","article-title":"Infusion of exogenous cholecystokinin-8, gastrin releasing peptide-29 and their combination reduce body weight in diet-induced obese male rats","volume":"109","author":"Mhalhal","year":"2017","journal-title":"Appetite"},{"issue":"7","key":"10.1016\/j.physbeh.2021.113456_bib0201","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.2337\/db12-1204","article-title":"Combination of obesity and high-fat feeding diminishes sensitivity to GLP-1R agonist exendin-4","volume":"62","author":"Duca","year":"2013","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0202","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ijo.2012.45","article-title":"Decreased intestinal nutrient response in diet-induced obese rats: role of gut peptides and nutrient receptors","volume":"37","author":"Duca","year":"2005","journal-title":"Int. J. Obes."},{"issue":"11","key":"10.1016\/j.physbeh.2021.113456_bib0203","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.peptides.2008.07.001","article-title":"Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood\u2013brain barrier","volume":"29","author":"Banks","year":"1980","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0204","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.0300-0664.2001.01456.x","article-title":"Weight loss increases circulating levels of ghrelin in human obesity","volume":"56","author":"Hansen","year":"2002","journal-title":"Clin. Endocrinol. (Oxford)"},{"issue":"9","key":"10.1016\/j.physbeh.2021.113456_bib0205","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1381\/0960892042386904","article-title":"Fasting plasma ghrelin concentrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia","volume":"14","author":"Fr\u00fchbeck","year":"2004","journal-title":"Obes. Surg."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0206","first-page":"177","article-title":"Relationship between hunger and plasma cholecystokinin during weight reduction with a very low calorie diet","volume":"17","author":"Lieverse","year":"1993","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0207","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1210\/jc.2003-031471","article-title":"Circulating ghrelin is sensitive to changes in body weight during a diet and exercise program in normal-weight young women","volume":"89","author":"Leidy","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.physbeh.2021.113456_bib0208","first-page":"4370","article-title":"Taste-related reward is associated with weight loss following bariatric surgery","volume":"130","author":"Smith","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.physbeh.2021.113456_bib0209","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of bariatric surgery on mortality in swedish obese subjects","volume":"357","author":"Sj\u00f6str\u00f6m","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.physbeh.2021.113456_bib0210","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s11695-014-1344-5","article-title":"Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect","volume":"24","author":"Lee","year":"2014","journal-title":"Obes. Surg."},{"issue":"7","key":"10.1016\/j.physbeh.2021.113456_bib0211","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1210\/jc.2002-021734","article-title":"Ghrelin and adipose tissue regulatory peptides: Effect of gastric bypass surgery in obese humans","volume":"88","author":"Holdstock","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.physbeh.2021.113456_bib0212","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1210\/jc.2010-2876","article-title":"Changes in glucose homeostasis after roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides","volume":"96","author":"Falk\u00e9n","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0213","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11695-009-9989-1","article-title":"The gut hormone response following roux-en-Y gastric bypass: cross-sectional and prospective study","volume":"20","author":"Pournaras","year":"2009","journal-title":"Obes. Surg."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0214","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11695-007-9056-8","article-title":"Early changes in ghrelin following roux-en-Y gastric bypass: influence of vagal nerve functionality?","volume":"17","author":"Sundbom","year":"2007","journal-title":"Obes. Surg."},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0215","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/SLA.0b013e3180caa3e3","article-title":"Gut hormones as mediators of appetite and weight loss after roux-en-Y gastric bypass","volume":"246","author":"le Roux","year":"2007","journal-title":"Ann. Surg."},{"issue":"7","key":"10.1016\/j.physbeh.2021.113456_bib0216","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1007\/s11695-012-0621-4","article-title":"Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects","volume":"22","author":"Jacobsen","year":"2012","journal-title":"Obes. Surg."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0217","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/bjs.5227","article-title":"Progressive rise in gut hormone levels after roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety","volume":"93","author":"Borg","year":"2006","journal-title":"Br. J. Surg."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0218","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/SLA.0b013e31815f6e77","article-title":"Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects","volume":"247","author":"Mor\u00ednigo","year":"2008","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0219","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1381\/096089203321136539","article-title":"Ghrelin: A gut-brain hormone: Effect of gastric bypass surgery","volume":"13","author":"Geloneze","year":"2003","journal-title":"Obes. Surg."},{"issue":"7","key":"10.1016\/j.physbeh.2021.113456_bib0220","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1381\/0960892054621071","article-title":"Pre- and post-prandial plasma ghrelin levels do not correlate with satiety or failure to achieve a successful outcome after roux-en-Y gastric bypass","volume":"15","author":"Christou","year":"2005","journal-title":"Obes. Surg."},{"issue":"7","key":"10.1016\/j.physbeh.2021.113456_bib0221","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.2337\/dc09-2107","article-title":"The importance of caloric restriction in the early improvements in insulin sensitivity after roux-en-Y gastric bypass surgery","volume":"33","author":"Isbell","year":"2010","journal-title":"Diabetes Care."},{"issue":"7","key":"10.1016\/j.physbeh.2021.113456_bib0222","first-page":"1108","article-title":"Short-term effects of gastric bypass surgery on circulating ghrelin levels","volume":"12","author":"Mor\u00ednigo","year":"2004","journal-title":"Obes. (Silver Spring, Md.)"},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0223","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jss.2007.02.022","article-title":"Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: A preliminary study","volume":"141","author":"Whitson","year":"2007","journal-title":"J. Surg. Res."},{"issue":"9","key":"10.1016\/j.physbeh.2021.113456_bib0224","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/oby.2006.179","article-title":"Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels","volume":"14","author":"Korner","year":"2006","journal-title":"Obes. (Silver Spring)"},{"issue":"12","key":"10.1016\/j.physbeh.2021.113456_bib0225","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1210\/jc.2015-3065","article-title":"Gastrointestinal hormones and weight loss maintenance following roux-en-Y gastric bypass","volume":"100","author":"de Hollanda","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0226","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1210\/jc.2002-021309","article-title":"Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects","volume":"88","author":"Faraj","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0227","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2014-1658","article-title":"Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations","volume":"100","author":"J\u00f8rgensen","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0228","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/01.sla.0000133117.12646.48","article-title":"The early effect of the roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism","volume":"240","author":"Rubino","year":"2004","journal-title":"Ann. Surg."},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0229","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00000658-199006000-00016","article-title":"Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty","volume":"211","author":"Kellum","year":"1990","journal-title":"Ann. Surg."},{"issue":"11","key":"10.1016\/j.physbeh.2021.113456_bib0230","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ijo.2013.15","article-title":"Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after roux-en-Y gastric bypass","volume":"37","author":"Dirksen","year":"2005","journal-title":"Int. J. Obes."},{"issue":"9","key":"10.1016\/j.physbeh.2021.113456_bib0231","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.2337\/db13-0022","article-title":"Exaggerated glucagon-like peptide 1 response is important for improved [beta]-cell function and glucose tolerance after roux-en-y gastric bypass in patients with type 2 diabetes.(ORIGINAL ARTICLE)","volume":"62","author":"Jorgensen","year":"2013","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0232","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2337\/db13-1307","article-title":"Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after roux-en-Y gastric bypass","volume":"63","author":"Bojsen-M\u00f8ller","year":"2014","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0233","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/db14-0558","article-title":"GLP-1 plays a limited role in improved glycemia shortly after roux-en-Y gastric bypass: a comparison with intensive lifestyle modification","volume":"64","author":"Vetter","year":"2015","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.physbeh.2021.113456_bib0234","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1007\/s00125-013-3003-0","article-title":"Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals","volume":"56","author":"Jacobsen","year":"2013","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.physbeh.2021.113456_bib0235","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s11695-014-1316-9","article-title":"Effects of meal size on the release of GLP-1 and PYY after roux-en-Y gastric bypass surgery in obese subjects with or without type 2 diabetes","volume":"24","author":"Yan","year":"2014","journal-title":"Obes. Surg."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0236","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11605-009-1060-y","article-title":"Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost","volume":"14","author":"Campos","year":"2009","journal-title":"J. Gastrointest. Surg."},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0237","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.soard.2007.08.004","article-title":"Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with roux-en-Y gastric bypass but not adjustable gastric banding","volume":"3","author":"Korner","year":"2007","journal-title":"Surg. Obes. Relat. Dis."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0238","article-title":"Acute and long-term effects of roux-en-Y gastric bypass on glucose metabolism in subjects with type 2 diabetes and normal glucose tolerance","volume":"303","author":"J\u00f8rgensen","year":"2012","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0239","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.12087","article-title":"Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after roux-en-Y gastric bypass","volume":"25","author":"Dirksen","year":"2013","journal-title":"Neurogastroenterol. Motil."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0240","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1463-1326.2011.01358.x","article-title":"Gastric bypass surgery, but not caloric restriction, decreases dipeptidyl peptidase-4 activity in obese patients with type 2 diabetes","volume":"13","author":"Alam","year":"2011","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0241","first-page":"60","article-title":"Appetite suppressant activity in plasma of rats after intestinal bypass surgery","volume":"243","author":"Atkinson","year":"1982","journal-title":"Am. J. Physiol."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0242","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ijo.2011.126","article-title":"Exogenous peptide YY3-36 and exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after roux-en-Y gastric bypass","volume":"36","author":"Fenske","year":"2005","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.physbeh.2021.113456_bib0243","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.physbeh.2013.03.027","article-title":"Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after roux-en-Y gastric bypass","volume":"121","author":"Abegg","year":"2013","journal-title":"Physiol. Behav."},{"issue":"9","key":"10.1016\/j.physbeh.2021.113456_bib0244","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.soard.2019.04.008","article-title":"GLP-1 and PYY3-36 reduce high-fat food preference additively after roux-en-Y gastric bypass in diet-induced obese rats","volume":"15","author":"Dischinger","year":"2019","journal-title":"Surg. Obes. Relat. Dis."},{"key":"10.1016\/j.physbeh.2021.113456_bib0245","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.amsu.2016.11.007","article-title":"Selective beneficial cardiometabolic effects of vertical sleeve gastrectomy are predominantly mediated through glucagon-like peptide (GLP-1) in zucker diabetic fatty rats","volume":"12","author":"Kumar","year":"2016","journal-title":"Annals Med. Surg."},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0246","first-page":"751","article-title":"Roux-en-Y gastric bypass in rats increases sucrose taste-related motivated behavior independent of pharmacological GLP-1-receptor modulation","volume":"302","author":"Mathes","year":"2012","journal-title":"Am. J. Physiol."},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0247","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s11695-020-04403-9","article-title":"Gastric bypass improves obesity and glucose tolerance independent of gastric pouch size","volume":"30","author":"Xu","year":"2020","journal-title":"Obes. Surg."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0248","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.gastro.2012.09.009","article-title":"The effects of vertical sleeve gastrectomy in rodents are ghrelin independent","volume":"144","author":"Chambers","year":"1943","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0249","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.molmet.2013.11.010","article-title":"Effects of roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency","volume":"3","author":"Mokadem","year":"2014","journal-title":"Mol. Metab. (Germany)"},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0250","article-title":"GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents","volume":"306","author":"Ye","year":"2014","journal-title":"Am. J. Physiol."},{"issue":"7","key":"10.1016\/j.physbeh.2021.113456_bib0251","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.2337\/db12-1498","article-title":"Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like peptide 1 receptor deficiency","volume":"62","author":"Wilson-Perez","year":"2013","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0252","first-page":"967","article-title":"Gastric bypass surgery alters behavioral and neural taste functions for sweet taste in obese rats","volume":"299","author":"Hajnal","year":"2010","journal-title":"Am. J. Physiol."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0253","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2337\/db10-0566","article-title":"Diet and gastrointestinal bypass-induced weight loss: The roles of ghrelin and peptide YY","volume":"60","author":"Chandarana","year":"2011","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.physbeh.2021.113456_bib0254","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1210\/en.2005-0473","article-title":"Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice","volume":"146","author":"Talsania","year":"2005","journal-title":"Endocrinology (Philadelphia)"},{"key":"10.1016\/j.physbeh.2021.113456_bib0255","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.molmet.2019.05.004","article-title":"Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice","volume":"25","author":"Boland","year":"2019","journal-title":"Mol. Metab. (Germany)"},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0256","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1053\/j.gastro.2015.10.009","article-title":"Differences in alimentary glucose absorption and intestinal disposal of blood glucose after roux-en-Y gastric bypass vs sleeve gastrectomy","volume":"150","author":"Cavin","year":"1943","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0257","doi-asserted-by":"crossref","first-page":"e65696","DOI":"10.1371\/journal.pone.0065696","article-title":"Hypertrophy dependent doubling of L-cells in roux-en-Y gastric bypass operated rats","volume":"8","author":"Hansen","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0258","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.12034","article-title":"Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats","volume":"25","author":"Mumphrey","year":"2013","journal-title":"Neurogastroenterol. Motil."},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0259","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.soard.2015.03.021","article-title":"Mucosal glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide cell numbers in the super-obese human foregut after gastric bypass","volume":"11","author":"Nerg\u00e5rd","year":"2015","journal-title":"Surg Obes Relat Dis"},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0260","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/nmo.12034","article-title":"Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats","volume":"25","author":"Mumphrey","year":"2013","journal-title":"Neurogastroenterol. Motil."},{"issue":"7","key":"10.1016\/j.physbeh.2021.113456_bib0261","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.molmet.2014.07.009","article-title":"Altered ghrelin secretion in mice in response to diet-induced obesity and roux-en-Y gastric bypass","volume":"3","author":"Uchida","year":"2014","journal-title":"Mol. Metab. (Germany)"},{"issue":"8","key":"10.1016\/j.physbeh.2021.113456_bib0262","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1007\/s11695-014-1547-9","article-title":"Sleeve gastrectomy does not cause hypertrophy and reprogramming of intestinal glucose metabolism in rats","volume":"25","author":"Mumphrey","year":"2015","journal-title":"Obes. Surg."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0263","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.12087","article-title":"Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after roux-en-Y gastric bypass","volume":"25","author":"Dirksen","year":"2013","journal-title":"Neurogastroenterol. Motil."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0264","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.soard.2011.09.025","article-title":"Metabolic effects of sleeve gastrectomy in female rat model of diet-induced obesity","volume":"9","author":"Brinckerhoff","year":"2013","journal-title":"Surg. Obes. Relat. Dis."},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0265","article-title":"Gastric bypass in female rats lowers concentrated sugar solution intake and preference without affecting brief-access licking after long-term sugar exposure","volume":"318","author":"Hyde","year":"2020","journal-title":"Am. J. Physiol."},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0266","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.euroneuro.2016.03.010","article-title":"Ghrelin treatment prevents development of activity based anorexia in mice","volume":"26","author":"Legrand","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.physbeh.2021.113456_bib0267","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1507\/endocrj.K09E-168","article-title":"Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study","volume":"56","author":"Hotta","year":"2009","journal-title":"Endocr. J."},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0268","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1176\/appi.ajp.2018.18101125","article-title":"Olanzapine versus placebo in adult outpatients with anorexia nervosa: A randomized clinical trial","volume":"176","author":"Attia","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.physbeh.2021.113456_bib0269","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1176\/appi.ajp.2008.07121900","article-title":"Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: A randomized, double-blind, placebo-controlled trial","volume":"165","author":"Bissada","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.physbeh.2021.113456_bib0270","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.npep.2015.12.010","article-title":"The atypical antipsychotic, olanzapine, potentiates ghrelin-induced receptor signaling: an in vitro study with cells expressing cloned human growth hormone secretagogue receptor","volume":"58","author":"Tagami","year":"2015","journal-title":"Neuropeptides (Edinburgh)."},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0271","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1017\/S1461145713001697","article-title":"Hypothalamic ghrelin signalling mediates olanzapine-induced hyperphagia and weight gain in female rats","volume":"17","author":"Zhang","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0272","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.psyneuen.2007.02.005","article-title":"Olanzapine-induced weight gain in anorexia nervosa: Involvement of leptin and ghrelin secretion?","volume":"32","author":"Brambilla","year":"2007","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0273","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.orcp.2015.03.005","article-title":"Improvement in binge eating in non-diabetic obese individuals after 3 months of treatment with liraglutide \u2013 a pilot study","volume":"9","author":"Robert","year":"2015","journal-title":"Obes. Res. Clin. Pract."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0274","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.dsx.2020.03.009","article-title":"Dulaglutide reduces binge episodes in type 2 diabetic patients with binge eating disorder: a pilot study","volume":"14","author":"Da Porto","year":"2020","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"issue":"10","key":"10.1016\/j.physbeh.2021.113456_bib0275","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1172\/JCI74726","article-title":"Estrogens stimulate serotonin neurons to inhibit binge-like eating in mice","volume":"124","author":"Cao","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.physbeh.2021.113456_bib0276","doi-asserted-by":"crossref","unstructured":"Drucker DJ, Buse JB, Taylor K, et\u00a0al. Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: A randomised, open-label, non-inferiority study. The Lancet (British edition). 2008;372(9645):1240-1250. https:\/\/search.datacite.org\/works\/10.1016\/s0140-6736(08)61206-4. doi: 10.1016\/s0140-6736(08)61206-4.","DOI":"10.1016\/S0140-6736(08)61206-4"},{"key":"10.1016\/j.physbeh.2021.113456_bib0277","first-page":"1606","volume":"374","author":"Astrup","year":"2009"},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0278","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2337\/dc09-1203","article-title":"Effects of exenatide and lifestyle modification on body weight and glucose tolerance in obese subjects with and without pre-diabetes","volume":"33","author":"Rosenstock","year":"2010","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0279","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.diabres.2012.02.016","article-title":"Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes","volume":"97","author":"Horowitz","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0280","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ijo.2013.162","article-title":"Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults","volume":"38","author":"van Can","year":"2005","journal-title":"Int. J. Obes."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0281","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/0091270010367653","article-title":"Effect of administration time of exenatide on satiety responses, blood glucose, and adverse events in healthy volunteers","volume":"51","author":"Pinelli","year":"2011","journal-title":"J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.physbeh.2021.113456_bib0282","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/mp.2017.91","article-title":"A hippocampus to prefrontal cortex neural pathway inhibits food motivation through glucagon-like peptide-1 signaling","volume":"23","author":"Hsu","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.physbeh.2021.113456_bib0283","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cobeha.2016.02.005","article-title":"GLP-1 influences food and drug reward","volume":"9","author":"Hayes","year":"2016","journal-title":"Curr. Opin. Behav. Sci."},{"issue":"9","key":"10.1016\/j.physbeh.2021.113456_bib0284","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/dom.12506","article-title":"Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans","volume":"17","author":"van Bloemendaal","year":"2015","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0285","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0286","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/ijo.2011.203","article-title":"Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analogue, liraglutide","volume":"36","author":"Astrup","year":"2012","journal-title":"Int. J. Obes."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0287","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1463-1326.2010.01356.x","article-title":"Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes","volume":"13","author":"Garber","year":"2011","journal-title":"Diabetes Obes. Metab."},{"issue":"6-7","key":"10.1016\/j.physbeh.2021.113456_bib0288","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/00365521.2017.1293154","article-title":"Bariatric surgery - time to replace with GLP-1?","volume":"52","author":"Webb","year":"2017","journal-title":"Scand. J. Gastroenterol."},{"issue":"9951","key":"10.1016\/j.physbeh.2021.113456_bib0289","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(14)60976-4","article-title":"Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): A randomised, open-label, phase 3, non-inferiority trial","volume":"384","author":"Dungan","year":"2014","journal-title":"Lancet North Am. Ed."},{"issue":"4","key":"10.1016\/j.physbeh.2021.113456_bib0290","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S2213-8587(13)70214-6","article-title":"Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): A randomised, open-label, multicentre, non-inferiority phase 3 study","volume":"2","author":"Pratley","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"9683","key":"10.1016\/j.physbeh.2021.113456_bib0291","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(09)60659-0","article-title":"Liraglutide once a day versus exenatide twice a day for type 2 diabetes: A 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)","volume":"374","author":"Buse","year":"2009","journal-title":"Lancet North Am. Ed."},{"issue":"209","key":"10.1016\/j.physbeh.2021.113456_bib0292","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007218","article-title":"Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans","volume":"5","author":"Finan","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.physbeh.2021.113456_bib0293","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2018.09.009","article-title":"LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept","volume":"18","author":"Coskun","year":"2018","journal-title":"Mol. Metab. (Germany)"},{"issue":"10160","key":"10.1016\/j.physbeh.2021.113456_bib0294","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/S0140-6736(18)32260-8","article-title":"Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: A randomised, placebo-controlled and active comparator-controlled phase 2 trial","volume":"392","author":"Frias","year":"2018","journal-title":"Lancet North Am. Ed."},{"key":"10.1016\/j.physbeh.2021.113456_bib0295","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.appet.2018.05.131","article-title":"A GLP-1:CCK fusion peptide harnesses the synergistic effects on metabolism of CCK-1 and GLP-1 receptor agonism in mice","volume":"127","author":"Hornigold","year":"2018","journal-title":"Appetite"},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0296","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.molmet.2017.02.002","article-title":"Monomeric GLP-1\/GIP\/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice","volume":"6","author":"Jall","year":"2017","journal-title":"Mol. Metab. (Germany)"},{"key":"10.1016\/j.physbeh.2021.113456_bib0297","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.peptides.2017.12.021","article-title":"Gut hormone polyagonists for the treatment of type 2 diabetes","volume":"100","author":"Brandt","year":"1980","journal-title":"Peptides"},{"issue":"6","key":"10.1016\/j.physbeh.2021.113456_bib0298","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/joim.12837","article-title":"Peptide-based multi-agonists: A new paradigm in metabolic pharmacology","volume":"284","author":"Brandt","year":"2018","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.physbeh.2021.113456_bib0299","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41366-019-0386-0","article-title":"Long-acting CCK analogue NN9056 lowers food intake and body weight in obese g\u00f6ttingen minipigs","volume":"44","author":"Christoffersen","year":"2005","journal-title":"Int. J. Obes."},{"issue":"11","key":"10.1016\/j.physbeh.2021.113456_bib0300","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1080\/17460441.2019.1646243","article-title":"Novel approaches to anti-obesity drug discovery with gut hormones over the past 10 years","volume":"14","author":"Rose","year":"2019","journal-title":"Expert Opin. Drug Discovery"},{"issue":"1","key":"10.1016\/j.physbeh.2021.113456_bib0301","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s11096-015-0219-8","article-title":"The effects of GLP-1 analogues in obese, insulin-using type 2 diabetes in relation to eating behaviour","volume":"38","author":"de Boer","year":"2015","journal-title":"Int. J. Clin. Pharm."},{"issue":"11","key":"10.1016\/j.physbeh.2021.113456_bib0302","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1210\/jc.2004-0353","article-title":"Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa","volume":"89","author":"Hotta","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.physbeh.2021.113456_bib0303","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamasurg.2013.3654","article-title":"The effectiveness and risks of bariatric surgery: An updated systematic review and meta-analysis, 2003-2012","volume":"149","author":"Chang","year":"2013","journal-title":"JAMA Surg."},{"issue":"5","key":"10.1016\/j.physbeh.2021.113456_bib0304","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2018.03.014","article-title":"Prevalence and correlates of DSM-5\u2013Defined eating disorders in a nationally representative sample of U.S. adults","volume":"84","author":"Udo","year":"2018","journal-title":"Biol. Psychiatry (1969)"}],"container-title":["Physiology &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938421001487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938421001487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:16:57Z","timestamp":1758478617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938421001487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":304,"alternative-id":["S0031938421001487"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2021.113456","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal peptides in eating-related disorders","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2021.113456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113456"}}